According to Collegium Pharmaceutical 's latest financial reports the company's total debt is ยฃ0.61 Billion. A companyโs total debt is the sum of all current and non-current debts.
Year | Total debt | Change |
---|---|---|
2024-12-31 | ยฃ0.68 B | 29.38% |
2023-12-31 | ยฃ0.52 B | -9.71% |
2022-12-31 | ยฃ0.58 B | 205.8% |
2021-12-31 | ยฃ0.19 B | -1.99% |
2020-12-31 | ยฃ0.19 B | 1087.65% |
2019-12-31 | ยฃ16.46 M | 81.77% |
2018-12-31 | ยฃ9.05 M | 727.87% |
2017-12-31 | ยฃ1.09 M | -67.43% |
2016-12-31 | ยฃ3.36 M | -26.91% |
2015-12-31 | ยฃ4.59 M | -44.97% |
2014-12-31 | ยฃ8.35 M | 1316.31% |
2013-12-31 | ยฃ0.58 M |
Company | Total debt/th> | differencediff. | Country |
---|---|---|---|
![]() Agile Therapeutics
AGRX | ยฃ0.21 M | -99.97% | ๐บ๐ธ USA |
![]() Horizon Therapeutics
HZNP | ยฃ1.87 B | 202.94% | ๐ฎ๐ช Ireland |
![]() United Therapeutics UTHR | ยฃ0.14 B | -76.31% | ๐บ๐ธ USA |
![]() KemPharm KMPH | ยฃ16.93 M | -97.26% | ๐บ๐ธ USA |